Tom Jin, Ph.D., Chair of BOD and CTO
Dr. Jin has over 20 years experiences in pharmaceutical R&D in both academia and industrial environment since his graduation from the Ph.D. program of University of Toronto. He is the major inventor of a number of new delivery systems including the sustained-release microspheres for native proteins (EasySphere, EasySphere+ and EasySphere2) and phase-transition microneedle patch (PTM), the two proven to be practically feasible by pre-clinic efficacy and PK studies.
Hua Zhu, Ph.D., VP, in charge of biologic study and US operation
Zhong Yin, Ph.D., VP, in charge of product development and China operation |
|
